NBY
AMEX · Pharmaceuticals
Novabay Pharmaceuticals Inc
$1.14
-0.08 (-6.56%)
Open$1.25
Previous Close$1.22
Day High$1.27
Day Low$1.14
52W High$99.75
52W Low$1.01
Volume—
Avg Volume312.3K
Market Cap51.92M
P/E Ratio—
EPS$-4.09
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 134.72M | 128.16M | 19.57M |
| Net Income | -99,482,873 | -85,173,692 | 4.44M |
| Profit Margin | -73.9% | -70.2% | 22.7% |
| EBITDA | -98,505,304 | -89,022,106 | 7.02M |
| Free Cash Flow | — | — | 4.00M |
| Rev Growth | +5.1% | +5.1% | -0.9% |
| Debt/Equity | 0.34 | 0.34 | 0.49 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |